Strong Human Data. Zero Canine Trials. Real Thyroid Risk.
Ashwagandha is one of the most popular adaptogens in human wellness, backed by randomized controlled trials showing reduced cortisol, lower stress scores, and measurable thyroid hormone changes. The temptation to extend those findings to dogs is understandable. But as of 2026, not a single published randomized clinical trial of ashwagandha has been conducted in dogs.
This gap between human promise and canine proof matters — especially because ashwagandha actively modulates thyroid hormones, creating genuine risk for dogs already on thyroid medication.
The herb (Withania somnifera) belongs to the Solanaceae (nightshade) family. Its active compounds, withanolides, influence the hypothalamic-pituitary-adrenal axis, touching cortisol, thyroid hormones, and neurotransmitter systems simultaneously.
Mechanism of Action: How Withanolides Work
Withanolides are steroidal lactones that exert their effects through multiple pathways simultaneously. Withaferin A and withanolide D are the most pharmacologically active compounds. They modulate the HPA axis by influencing cortisol release from the adrenal cortex, reducing the exaggerated cortisol response to chronic stressors.
At the molecular level, withanolides inhibit NF-kB signaling, reduce COX-2 expression, and modulate GABA-A receptor activity — the same receptor targeted by benzodiazepines. This GABAergic activity likely accounts for the anxiolytic and mild sedative effects reported in human trials.
The thyroid-stimulating mechanism appears to involve direct action on thyroid peroxidase activity and thyroid-stimulating hormone (TSH) modulation. In the 2018 subclinical hypothyroid study, T3 rose by 41.5% and T4 by 19.6% after 8 weeks — these are not marginal changes. In dogs, where hypothyroidism is the most common endocrine disorder, this thyroid-stimulating potential carries both theoretical appeal and genuine clinical risk.
Where the Evidence Actually Lives
In humans — substantial and growing:
- A 2012 randomized, double-blind, placebo-controlled trial showed that ashwagandha root extract (300 mg twice daily) significantly reduced serum cortisol and perceived stress scores in chronically stressed adults.
- A 2018 study in subclinical hypothyroid patients found that 600 mg/day for 8 weeks significantly increased T3 and T4 levels. This is not a subtle effect — it suggests direct thyroid stimulation.
In dogs — essentially nothing:
- No randomized clinical trials. Zero.
- Ashwagandha appears in some commercial canine calming products, usually blended with L-theanine, chamomile, or valerian. But no isolated efficacy data exists for the ashwagandha component.
- The root extract is not considered toxic to dogs at moderate doses, but canine dose-response data is missing.
The thyroid interaction you cannot ignore:
- Ashwagandha may boost thyroid hormone production. For dogs with subclinical hypothyroidism, this sounds appealing. For dogs already on levothyroxine, it is dangerous — stacking ashwagandha on top of replacement therapy risks pushing your dog into iatrogenic hyperthyroidism.
For anxiety — better options exist:
- The cortisol-lowering mechanism is theoretically relevant for dogs with anxiety. But L-theanine has multiple canine trials, a well-characterized safety profile, and no thyroid interaction. It is the more rational first choice.
Dosing Is Guesswork
Without canine dose-response studies, all dosing is extrapolation:
- Conservative range: 5-10 mg/kg/day of standardized extract (2.5-5% withanolides)
- Small dogs (<10 kg): 50-100 mg/day
- Medium dogs (10-25 kg): 100-250 mg/day
- Large dogs (>25 kg): 250-500 mg/day
These are rough estimates based on human data and general interspecies scaling. Start at the lower end and watch closely for any adverse signs.
Split dosing twice daily with food may improve tolerability and maintain steadier blood levels. Withaferin A has a relatively short half-life, so single large doses are more likely to cause gastrointestinal irritation than divided doses.
If You Proceed, Quality Matters
- KSM-66 and Sensoril are the two most-studied branded extracts in human trials
- Standardize to withanolide content — minimum 2.5%
- Root extracts only. Leaf extracts contain higher concentrations of withaferin A, which has more cytotoxic activity.
Breed-Specific Considerations
Breed-specific endocrine vulnerabilities make ashwagandha riskier for certain dogs:
- Golden Retrievers and Labrador Retrievers: Both breeds have elevated rates of hypothyroidism. Adding a thyroid-stimulating compound to a breed already prone to thyroid dysfunction introduces an unpredictable variable — especially if subclinical hypothyroidism has not yet been diagnosed.
- Doberman Pinschers: High autoimmune thyroiditis prevalence. Ashwagandha’s immune-modulating properties could theoretically worsen autoimmune thyroid destruction.
- Siberian Huskies and Alaskan Malamutes: Breeds with known autoimmune predispositions. The immunostimulatory component of ashwagandha adds unnecessary risk.
- Toy and small breeds (Chihuahuas, Yorkshire Terriers): Lower body mass means dosing errors have proportionally larger effects. The margin between a conservative dose and excessive exposure is smaller in a 3 kg dog than a 30 kg dog.
More Caution Than Most Herbal Supplements
Ashwagandha demands more vigilance than the typical botanical supplement.
Do not use in:
- Dogs on levothyroxine or with managed hypothyroidism — thyroid hormone elevation risk is real
- Dogs with autoimmune conditions where immune stimulation could be harmful
- Pregnant or nursing dogs — abortifacient properties are documented in animal models
- Dogs with liver disease — the 2021 Journal of Ethnopharmacology safety review noted rare but confirmed cases of liver injury in humans, triggering regulatory caution in some European markets
Drug interactions to be aware of:
- May amplify the effects of sedatives, anxiolytics, and immunosuppressants
- Potential additive effect with thyroid hormone replacement (levothyroxine) — risk of iatrogenic hyperthyroidism
- May enhance the hypoglycemic effects of insulin or oral antidiabetics
- GI upset (diarrhea, vomiting) at higher doses, particularly with leaf-based extracts
Monitoring if you proceed: Check thyroid panel (T3, T4, free T4, TSH) at baseline before starting ashwagandha, then recheck at 4 weeks and 8 weeks. Any upward drift in thyroid hormones warrants discontinuation and veterinary evaluation.
The Honest Verdict
Ashwagandha is a well-studied adaptogen — in humans. In dogs, the evidence base is essentially zero, and the thyroid interaction creates a risk profile that most other supplements do not carry. For anxiety, L-theanine or melatonin are safer, better-supported first choices. If you still want to try ashwagandha for your dog, do it conservatively, under veterinary supervision, and never without explicit approval if your dog takes levothyroxine.
Related reads: L-Theanine for Dogs, Melatonin for Dogs, Anxiety, Hypothyroidism, Cognitive Decline
Frequently Asked Questions
Is ashwagandha safe for dogs? At conservative doses in healthy dogs, it appears well-tolerated, but canine safety studies are lacking. Dogs on thyroid medication, immunosuppressants, or with liver disease should not take ashwagandha.
Can ashwagandha replace my dog’s anxiety medication? No. Ashwagandha has not been studied in dogs for anxiety, and it should not replace veterinary-prescribed anxiolytics. It may be considered as an adjunct with veterinary approval.
Will ashwagandha help my hypothyroid dog? Potentially, but this is risky. Ashwagandha can increase thyroid hormone levels, which could interfere with levothyroxine dosing and lead to hyperthyroidism. Never add ashwagandha to a managed hypothyroid dog’s regimen without veterinary supervision.
How does ashwagandha compare to L-theanine for dog anxiety? L-theanine has multiple direct canine studies, a well-understood mechanism, and no significant drug interactions. Ashwagandha has stronger human data but minimal canine evidence and more interaction risk. L-theanine is the safer first choice.
Can I give my dog the same ashwagandha I take? Human ashwagandha supplements can technically be used, but ensure the dose is appropriate for your dog’s body weight, and that the product does not contain xylitol or other dog-toxic additives.
Related Science
- Circadian Rhythm and Dog Longevity
- Environmental Enrichment for Cognitive Health in Dogs
- Noise Phobia in Dogs: Physiological Impact and Longevity Implications
- Separation Anxiety and Health in Dogs: The Physiological Cost of Being Left Alone
- Anxiety Disorders and Canine Longevity: How Chronic Stress Shortens Lifespan
References
- Overview of ashwagandha: a rasayana of Ayurveda (AJTCAM, 2011)
- Ashwagandha for reducing stress and anxiety in adults (Indian Journal of Psychological Medicine, 2012)
- Ashwagandha effects on thyroid function (JACM, 2018)
- Withania somnifera safety review (Journal of Ethnopharmacology, 2021)